Hostname: page-component-586b7cd67f-gb8f7 Total loading time: 0 Render date: 2024-11-22T10:55:32.414Z Has data issue: false hasContentIssue false
  • English
  • Français

Expression and clinical significance of Ki-67, oestrogen and progesterone receptors in acoustic neuroma

Published online by Cambridge University Press:  01 August 2007

S Cafer ,
I Bayramoglu ,
N Uzum ,
M Yilmaz ,
L Memis  and
K Uygur
S Cafer
Affiliation:
Department of Otolaryngology, Gazi University, Besevler, Ankara, Turkey
I Bayramoglu*
Affiliation:
Department of Otolaryngology, Gazi University, Besevler, Ankara, Turkey
N Uzum
Affiliation:
Department of Pathology, Faculty of Medicine, Gazi University, Besevler, Ankara, Turkey
M Yilmaz
Affiliation:
Department of Otolaryngology, Gazi University, Besevler, Ankara, Turkey
L Memis
Affiliation:
Department of Pathology, Faculty of Medicine, Gazi University, Besevler, Ankara, Turkey
K Uygur
Affiliation:
Department of Otolaryngology, Gazi University, Besevler, Ankara, Turkey
*
Address for correspondence: Ismet Bayramoglu, 60.sk 20/6 Emek, Ankara, Turkey. Fax: +90 312 215 0589 E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

The objective was to assess the presence of Ki-67, and oestrogen and progesterone hormone receptors as well as their clinical correlates in acoustic neuroma.

Methods:

Medical records of 59 patients who were operated on for acoustic neuroma between 1995 and 2003 were evaluated retrospectively. Formaldehyde-fixed paraffin-embedded archival acoustic neuroma specimens of the patients were used for immunohistochemical assessments of oestrogen and progesterone hormone receptors, and Ki-67 proliferative marker.

Results:

Tumour sizes were small (<19 mm), medium (20–39 mm) and large (>40 mm) in 21, 35 and 3 patients, respectively. On immunohistochemistry, all samples were (+) for progesterone receptor and (–) for oestrogen receptor staining. Ki-67 staining was encountered in 34 of 59 (57.6 per cent) patients, and Ki-67 values ranged from 0 per cent to 10.9 per cent (mean 1.36 per cent). There was no correlation between Ki-67, gender, tumour size and symptoms of the patients (p > 0.05).

Conclusion:

Oestrogen is not an important hormone in acoustic neuroma due to the absence of oestrogen receptor expression in the tissue samples. Since the progesterone receptor is expressed in all acoustic neuroma samples, further studies are necessary to find out about the inhibitory effect of antiprogesterone treatment on acoustic neuroma growth, which may be important particularly in elderly people or high-risk patients. Although Ki-67 is expressed in the majority of acoustic neuromas, it is not an important marker in clinical practice due to a lack of any correlation with the clinical parameters.

Keywords

Biological Tumour MarkersEstrogenProgesteroneKi-67 AntigenAcoustic Neuroma
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 122 , Issue 2 , February 2008 , pp. 125 - 127
Copyright
Copyright © JLO (1984) Limited 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Goksu, N, Yilmaz, M, Bayramoglu, I, Aydil, U, Bayazit, YA. Evaluation of the results of endoscope-assisted acoustic neuroma surgery through posterior fossa approach. ORL J Otorhinolaryngol Relat Spec 2005;67:87–91CrossRefGoogle ScholarPubMed
2 Goksu, N, Bayazit, YA, Yilmaz, M, Bayramoglu, I. Surgical treatment of peripheral vertigo and vertiginous diseases. ORL J Otorhinolaryngol Relat Spec 2005;67:1–9CrossRefGoogle ScholarPubMed
3 Kasantikul, V, Brown, WJ. Estrogen receptors in acoustic neurilemmomas. Surg Neurol 1981;15:105–9CrossRefGoogle ScholarPubMed
4 Martuza, RL, Miller, DC, MacLaughlin, DT. Estrogen and progestin binding by cytosolic and nuclear fractions of human meningiomas. J Neurosurg 1985;62:750–6CrossRefGoogle ScholarPubMed
5 Whittle, I, Hawkins, RA, Miller, JD. Sex hormone receptors in intracranial tumors and normal brain. Eur J Surg Oncol 1987;13:303–7Google ScholarPubMed
6 Gerdes, J, Schwab, U, Lemke, H, Stein, H. Production of a mouse monoclonal antibody reactive with human nuclear antigen associated cell proliferation. Int J Cancer 1983;31:13–20CrossRefGoogle Scholar
7 Scholzen, T, Gerdes, J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000;182:311–223.0.CO;2-9>CrossRefGoogle ScholarPubMed
8 Schlehofer, B, Blettner, M, Wahrendorf, J. Association between brain tumors and menopausal status. J Natl Cancer Inst 1992;84:1346–9CrossRefGoogle ScholarPubMed
9 Caroll, RS, Zhang, JP, Black, PMcL. Hormone receptors in vestibular schwannomas. Acta Neurochir 1997;139:188–93CrossRefGoogle Scholar
10 Siglock, TJ, Rosenblat, SS, Finck, F, House, WF, Hitselberger, WE. Sex hormone receptors in acoustic neuromas. Am J Otol 1990;11:237–9Google ScholarPubMed
11 Klinken, L, Thomsen, J, Rasmussen, BB, Wiet, RJ, Tos, M. Estrogen and progesterone receptors in acoustic neuromas. Arch Otolaryngol Head Neck Surg 1990;116:202–4CrossRefGoogle ScholarPubMed
12 Curley, JWA, Ramsden, RT, Howell, A, Healy, K, Lye, RH. Oestrogen and progesterone receptors in acoustic neuroma. J Laryngol Otol 1990;104:865–7CrossRefGoogle ScholarPubMed
13 Monsell, EM, Wiet, RC. Estrogen and progesterone binding by acoustic neuroma tissue. Otolaryngol Head Neck Surg 1990;103:377–9CrossRefGoogle ScholarPubMed
14 Beatty, CW, Scheithauer, BW, Katzmann, JA, Roche, PC, Kjeldahl, KS, Ebersold, MJ. Acoustic schwannoma and pregnancy: a DNA flow cytometric, steroid hormone receptor, and proliferation marker study. Laryngoscope 1995;105:693–700CrossRefGoogle ScholarPubMed
15 Filipo, R, Petrangeli, E, Monini, S, Ortolani, F, Gulino, A, Barbara, M et al. Expression of steroid receptors in acoustic neuroma. Clin Otolaryngol 1995;20:413–17CrossRefGoogle ScholarPubMed
16 Markwalder, T, Waelti, E, Markwalder, RV. Estrogen and progestin receptors in acoustic and spinal neurilemmomas. Surg Neurol 1986;26:142–8CrossRefGoogle ScholarPubMed
17 Olson, JJ, Beck, D, Schlechte, J, Loh, PM. Effect of the antiprogesterone RU-38486 on meningioma implanted into nude mice. J Neurosurg 1987;66:584–7CrossRefGoogle ScholarPubMed
18 Lesser, THJ, Janzer, RC, Kleihues, P, Fisch, U. Clinical growth rate of acoustic schwannomas: correlation with the growth fraction as defined by the monoclonal antibody Ki-67. Skull Base Surg 1991;1:11–15CrossRefGoogle ScholarPubMed
19 Niemczyk, K, Vaneeclo, FM, Lecomte, MH, Lejeune, JP, Lemaitre, L, Skarzynski, H et al. Correlation between Ki-67 index and some clinical aspects of acoustic neuromas (vestibular schwannomas). Otolaryngol Head Neck Surg 2000;123:779–83CrossRefGoogle ScholarPubMed
20 Giangaspero, F, Doglioni, C, Rivano, MT, Pileri, S, Gerdes, J, Stein, H. Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67. Acta Neuropathol 1987;74:179–82CrossRefGoogle ScholarPubMed
21 Deckert, M, Reifenberger, G, Wechsler, W. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67. J Cancer Res Clin Oncol 1989;115:179–88CrossRefGoogle ScholarPubMed
22 Szeremeta, W, Monsell, EM, Rock, JP, Caccamo, DV. Proliferation indices of vestibular schwannomas by Ki-67 and proliferating cell nuclear antigen. Am J Otol 1995;16:616–19Google ScholarPubMed
23 Wennerberg, J, Mercke, U. Growth potential of acoustic neuromas. Am J Otol 1989;10:293–6Google ScholarPubMed
24 Charabi, S, Engel, P, Jacobsen, GK, Tos, M, Thomsen, J. Growth rate of acoustic neuroma expressed by Ki-67 nuclear antigen versus symptom duration. Ann Otol Rhinol Laryngol 1993;102:805–9CrossRefGoogle ScholarPubMed